Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

Hepatology International

Volumn 7, Issue 1, 2013, Pages 119-126

  Seto, Wai Kay ^a   Wong, Danny Ka Ho ^a   Fung, James ^a   Hung, Ivan Fan Ngai ^a   Yuen, John Chi Hang ^a   Tong, Teresa ^a   Lai, Ching Lung ^a,b   Yuen, Man Fung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic hepatitis B; HBeAg; HBsAg; HBV DNA; Kinetics

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ANTIGEN DETECTION; AREA UNDER THE CURVE; ARTICLE; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

EID: 84872498457     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9373-4     Document Type: Article

References (32)

1. J Fung WK Seto CL Lai, et al. 2011 Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy J Hepatol 54 2 195 200 21056499 10.1016/j.jhep.2010.06.031 1:CAS:528:DC%2BC3MXmsVylsQ%3D%3D
2. CJ Chu EB Keeffe SH Han, et al. 2003 Prevalence of HBV precore/core promoter variants in the United States Hepatology 38 3 619 628 12939588 10.1053/jhep.2003.50352 1:CAS:528:DC%2BD3sXnvVKjtrY%3D
3. JP Zarski P Marcellin V Leroy, et al. 2006 Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases J Hepatol 45 3 355 360 16750585 10.1016/j.jhep.2006.03.007
4. AM Di Bisceglie JG Waggoner JH Hoofnagle 1987 Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy Gastroenterology 93 6 1236 1241 3678741
5. CL Lai MF Yuen 2007 The natural history and treatment of chronic hepatitis B: A critical evaluation of standard treatment criteria and end points Ann Intern Med 147 1 58 61 17606962
6. JD Chen HI Yang UH Iloeje, et al. 2010 Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death Gastroenterology 138 5 1747 1754 20114048 10.1053/j.gastro.2010.01.042
7. MF Yuen HJ Yuan DK Wong, et al. 2005 Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications Gut 54 11 1610 1614 15871997 10.1136/gut.2005.065136
8. MR Brunetto F Oliveri B Coco, et al. 2002 Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study J Hepatol 36 2 263 270 11830339 10.1016/S0168-8278(01)00266-5 1:CAS:528:DC%2BD38Xit1eis7s%3D
9. JJ Feld M Ayers D El-Ashry, et al. 2007 Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B Hepatology 46 4 1057 1070 17654702 10.1002/hep.21811 1:CAS:528:DC%2BD2sXht1aksr3L
10. UH Iloeje HI Yang J Su, et al. 2006 Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 3 678 686 16530509 10.1053/j.gastro.2005.11.016
11. CJ Chen HI Yang J Su, et al. 2006 Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 1 65 73 16391218 10.1001/jama.295.1.65 1:CAS:528:DC%2BD28XhtlKqtQ%3D%3D
12. Chen CF, Lee WC, Yang HI, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011;141(4):1240-1248.e2
13. MF Yuen Y Tanaka N Shinkai, et al. 2008 Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels Gut 57 1 98 102 17483190 10.1136/gut.2007.119859 1:CAS:528:DC%2BD1cXitVKqt78%3D
14. J Fung CL Lai MF Yuen 2010 Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B Expert Rev Anti Infect Ther 8 6 717 726 20521898 10.1586/eri.10.45 1:CAS:528:DC%2BC3cXmvFaqtbo%3D
15. K Wursthorn M Lutgehetmann M Dandri, et al. 2006 Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B Hepatology 44 3 675 684 16941693 10.1002/hep.21282 1:CAS:528:DC%2BD28XhtVeqt7bM
16. T Volz M Lutgehetmann P Wachtler, et al. 2007 Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients Gastroenterology 133 3 843 852 17854594 10.1053/j.gastro.2007.06.057 1:CAS:528:DC%2BD2sXhtFarsrfP
17. AJ Thompson T Nguyen D Iser, et al. 2010 Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 6 1933 1944 20512987 10.1002/hep.23571 1:CAS:528:DC%2BC3cXnslyqsLc%3D
18. HL Chan VW Wong GL Wong, et al. 2010 A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B Hepatology 52 4 1232 1241 20648555 10.1002/hep.23803 1:CAS:528: DC%2BC3cXhtlejsrvL
19. J Jaroszewicz B Calle Serrano K Wursthorn, et al. 2010 Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective J Hepatol 52 4 514 522 20207438 10.1016/j.jhep.2010.01.014 1:CAS:528:DC%2BC3cXjvFKmsLc%3D
20. T Nguyen AJ Thompson S Bowden, et al. 2010 Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia J Hepatol 52 4 508 513 20206400 10.1016/j.jhep.2010.01.007 1:CAS:528: DC%2BC3cXjvFKmsLY%3D
21. MR Brunetto F Oliveri P Colombatto, et al. 2010 Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers Gastroenterology 139 2 483 490 20451520 10.1053/j.gastro. 2010.04.052 1:CAS:528:DC%2BC3cXpsVGnu7o%3D
22. J Liu HI Yang MH Lee, et al. 2010 Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study Gastroenterology 139 2 474 482 20434450 10.1053/j.gastro.2010. 04.048
23. TC Tseng CJ Liu TH Su, et al. 2011 Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters Gastroenterology 141 2 517 525 21672542 10.1053/j.gastro.2011.04.046 1:CAS:528:DC%2BC3MXpvFOqt7o%3D
24. HL Chan GL Wong CH Tse, et al. 2011 Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients J Infect Dis 204 3 408 414 21742839 10.1093/infdis/jir283 1:CAS:528:DC%2BC3MXovVKqsbo%3D
25. MF Yuen DK Wong J Fung, et al. 2008 HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma Gastroenterology 135 4 1192 1199 18722377 10.1053/j.gastro.2008.07.008 1:CAS:528:DC%2BD1cXht12lurrP
26. M Kuhns A McNamara A Mason, et al. 1992 Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen Gastroenterology 103 5 1649 1656 1385254 1:STN:280:DyaK3s%2FltFSrtA%3D%3D
27. CA Bill J Summers 2004 Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration Proc Natl Acad Sci USA 101 30 11135 11140 15258290 10.1073/pnas.0403925101 1:CAS:528:DC%2BD2cXmsVCmtb0%3D
28. DK Wong MF Yuen H Yuan, et al. 2004 Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients Hepatology 40 3 727 737 15349913 10.1002/hep.20353 1:CAS:528:DC%2BD2cXot1Ortbs%3D
29. T Kimura A Rokuhara Y Sakamoto, et al. 2002 Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load J Clin Microbiol 40 2 439 445 11825954 10.1128/JCM.40.2.439-445.2002 1:CAS:528:DC%2BD38XhvFGktbk%3D
30. E Tanaka A Matsumoto F Suzuki, et al. 2006 Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance Liver Int 26 1 90 96 16420514 10.1111/j.1478-3231. 2005.01200.x 1:CAS:528:DC%2BD28XisFCmu7s%3D
31. J Fung CL Lai J Young, et al. 2011 Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment Am J Gastroenterol 106 10 1766 1773 21826112 10.1038/ajg.2011.253 1:CAS:528:DC%2BC3MXht12jtbvN
32. M Sugiyama Y Tanaka T Kato, et al. 2006 Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens Hepatology 44 4 915 924 17006908 10.1002/hep.21345 1:CAS:528:DC%2BD28XhtFyqsrzK